Selected article for: "acute respiratory and lopinavir darunavir"
Author: Zarandi, Peyman Kheirandish; Zinatizadeh, Mohammad Reza; Zinatizadeh, Maryam; Yousefi, Mohammad Hadi; Rezaei, Nima
Title: SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
  • Cord-id: fc5tmt70
  • Document date: 2021_2_2
    • ID: fc5tmt70
    Snippet: INTRODUCTION: The world is witnessing the spread of one of the members of Coronaviruses (CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the 21st century. Considering the short time spent after its prevalence, limited information is known about the effect of the virus mechanism on different organs of the body; meanwhile the lack of specific treatment and vaccine for this virus has exposed millions of people to a big challenge. AREAS COVERED: The review articl
    Document: INTRODUCTION: The world is witnessing the spread of one of the members of Coronaviruses (CoVs) family, called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the 21st century. Considering the short time spent after its prevalence, limited information is known about the effect of the virus mechanism on different organs of the body; meanwhile the lack of specific treatment and vaccine for this virus has exposed millions of people to a big challenge. AREAS COVERED: The review article aims to describe the general and particular characteristics of CoVs, their classification, genome structure, host cell infection, cytokine storm, anti-viral treatments, and inhibition of COVID-19-related ER-mitochondrial stress. In addition, it refers to drugs such as Chloroquine/Hydroxychloroquine, Lopinavir/Ritonavir, darunavir, ribavirin, remdesivir, and favipiravir, which have undergone clinical trials for coronavirus disease 2019 (COVID-19) treatment. This analysis was derived from an extensive scientific literature search including Pubmed, ScienceDirect, and Google Scholar performed. EXPERT OPINION: The effectiveness rate and complications of these drugs can reveal new insights into the potential therapeutic goals for the disease. Moreover, lifestyle change can effectively prevent SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and liver cell: 1
    • abdominal pain and liver cell intestine: 1
    • abdominal pain and lopinavir ritonavir: 1, 2, 3, 4
    • abdominal pain and low number: 1
    • abdominal pain and lung infection: 1, 2, 3, 4
    • abdominal pain and lung tissue: 1, 2
    • abdominal pain and lung tissue damage: 1
    • abdominal pain and macrophage inflammation: 1
    • abdominal pain vomiting and acute ards respiratory distress syndrome: 1
    • abdominal pain vomiting and liver cell: 1
    • abdominal pain vomiting and liver cell intestine: 1
    • abdominal pain vomiting and lopinavir ritonavir: 1, 2, 3
    • abdominal pain vomiting and lung infection: 1, 2
    • abdominal pain vomiting and lung tissue: 1
    • abdominal pain vomiting diarrhea and liver cell: 1
    • abdominal pain vomiting diarrhea and liver cell intestine: 1
    • abdominal pain vomiting diarrhea and lopinavir ritonavir: 1, 2
    • abdominal pain vomiting diarrhea and lung infection: 1
    • abdominal pain vomiting diarrhea and lung tissue: 1